Romesh R. Subramanian
Direttore/Membro del Consiglio presso Ceptur Therapeutics, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jason Rhodes | M | 54 | 7 anni | |
| P. Peter Ghoroghchian | M | - |
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Rick Scalzo | M | 38 | 5 anni | |
| Edward Hurwitz | M | 60 | 6 anni | |
| Piyush Sharma | M | - | 7 anni | |
| Molly White | F | 64 | 4 anni | |
| John Najim | M | 48 | 5 anni | |
| Thomas-Christian Mix | M | 57 | 7 anni | |
| David Lubner | M | 60 | 4 anni | |
| Rafal Goraczniak | M | - |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Catherine Stehman-Breen | M | 61 | 5 anni | |
| Amy Reilly | F | 51 | 4 anni | |
| Dirk Kersten | M | 49 | 6 anni | |
| Aaron Royston | M | 40 |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Colin Walsh | M | 38 |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Wildon Farwell | M | 49 | 3 anni | |
| Oxana Beskrovnaya | M | 63 | 4 anni | |
| Jonathan McNeill | M | 39 | 5 anni | |
| Ashish Dugar | M | - | 3 anni | |
| John Davis | M | 56 | 4 anni | |
| Debra Feldman | F | 54 | 4 anni | |
| Aaron Kantoff | M | 29 |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Daniel Wilson | M | 53 | 4 anni | |
| Susanna High | F | 56 | 4 anni | |
| Daniel Heller | M | - |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
| Keith-Harrison Dewedoff | M | - |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Leonard Bell | M | 65 | 25 anni | |
| David Hallal | M | 56 | 10 anni | |
| Joshua Brumm | M | 46 | 5 anni | |
| David Brennan | M | 70 | 7 anni | |
| Arthur M. Krieg | M | 66 | 3 anni | |
| Stephen P. Squinto | M | 67 | 23 anni | |
| Brian Goff | M | 55 | 4 anni | |
| Italo Andres Zanzi | M | 50 |
Emory University
| 3 anni |
| Christopher Coughlin | M | 71 | 7 anni | |
| Mark Day | M | 52 | 2 anni | |
| Rana Strellis | F | - | 4 anni | |
| Ludwig Hantson | M | 61 | 4 anni | |
| Lawrence Klein | M | 41 | 4 anni | |
| Tina Beamon | F | - | 3 anni | |
| Mohammed Qatanani | M | 50 | 6 anni | |
| Peter D. Eberhart | M | - |
Emory University
| 3 anni |
| Felix Baker | M | 55 | 6 anni | |
| William Keller | M | 75 | 6 anni | |
| Rockford Norby | M | 89 | 18 anni | |
| Max E. Link | M | 84 | 22 anni | |
| Anne-Marie Law | F | 56 | 3 anni | |
| Paul Friedman | M | 81 | 4 anni | |
| Daniel Lynch | M | 65 | 9 anni | |
| M. Burns | F | 66 | 4 anni | |
| Rachel Lemberg | F | - |
Emory University
| 4 anni |
| Joseph Goldman | M | - |
Emory University
| 4 anni |
| Dan D. Shin | M | - |
Emory University
| 4 anni |
| Brian B. Lichter | M | - |
Emory University
| 4 anni |
| Josh Lynn | M | - |
Emory University
| 4 anni |
| Bret Kadison | M | - |
Emory University
| 4 anni |
| Matthew Robert Miller | M | 47 |
Emory University
| 4 anni |
| Matthew Ross | M | - |
Emory University
| 4 anni |
| Amanda Witt | F | - |
Emory University
| 3 anni |
| Yu Shi Guo | M | 52 |
Emory University
| 2 anni |
| David Karnovsky | M | - |
Emory University
| 4 anni |
| Mathew Farrell Kirschner | M | - |
Emory University
| 4 anni |
| Chris Lee | M | - |
Emory University
| 3 anni |
| Laurie Mundt | - | - |
Emory University
| 4 anni |
| Jonathan Dobres | M | 46 |
Emory University
| 4 anni |
| Deborah Backus | M | - |
Emory University
| 3 anni |
| Carrie Herz | F | - |
Emory University
| 4 anni |
| Amie Singer Piccola | F | - |
Emory University
| 3 anni |
| Nirav Thakker | M | - |
Emory University
| 4 anni |
| Kevin Burke | M | - |
Emory University
| 4 anni |
| Robbie Marcus | M | - |
Emory University
| 4 anni |
| Jonathan S. Newpol | M | 65 |
Emory University
| 4 anni |
| Isai Peimer | M | 46 |
Emory University
| 4 anni |
| Eric Lee Scher | M | - |
Emory University
| 4 anni |
| John M. Poma | M | 59 |
Emory University
| 3 anni |
| Harriet Robinson | M | 86 |
Emory University
| 9 anni |
| David Savett | M | 42 |
Emory University
| 3 anni |
| Gregory Chwatko | M | - |
Emory University
| 4 anni |
| Chris Fitze | M | - |
Emory University
| 4 anni |
| Jolie Brooke Chaikin | F | - |
Emory University
| 4 anni |
| Brad Neuman | M | - |
Emory University
| 4 anni |
| Jonathan Abshire | M | - |
Emory University
| 4 anni |
| Ben Johnson | M | 80 |
Emory University
| 13 anni |
| Jeffrey Warren Eisenstein | M | - |
Emory University
| 4 anni |
| Jeremy Davis | M | - |
Emory University
| 4 anni |
| Scott Michael Hendrickson | M | - |
Emory University
| 3 anni |
| Steven T. Liu | M | - |
Emory University
| 8 anni |
| Jonathan Starr | M | 47 |
Emory University
| 4 anni |
| Sameer Mehra Vijaykumar | M | - |
Emory University
| 2 anni |
| Heb James | M | - |
Emory University
| 4 anni |
| Jacob A. Steinfeld | M | - |
Emory University
| 4 anni |
| Richard F. Mattern | M | - |
Emory University
| 3 anni |
| David E. Barrett | M | - |
Emory University
| 4 anni |
| Jason S. Smith | M | - |
Emory University
| 4 anni |
| Vincent la Terza | M | - |
Emory University
| 6 anni |
| Ekaterina Vladimirovna Petelina | F | 50 |
Emory University
| 2 anni |
| Peter A. Krivkovich | M | - |
Emory University
| 4 anni |
| Kent Alexander | M | 65 |
Emory University
| - |
| Ethan Austin | M | - |
Emory University
| 4 anni |
| Drew Schechtman | M | - |
Emory University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Romesh R. Subramanian
- Contatti personali
